ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 84 filers reported holding ENZO BIOCHEM INC in Q3 2020. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $5,000 | -72.2% | 1,315 | -81.0% | 0.00% | – |
Q4 2020 | $18,000 | +350.0% | 6,932 | +236.0% | 0.00% | – |
Q3 2020 | $4,000 | -90.7% | 2,063 | -87.1% | 0.00% | – |
Q2 2020 | $43,000 | +38.7% | 15,972 | +17.2% | 0.00% | – |
Q1 2020 | $31,000 | +106.7% | 13,627 | +138.1% | 0.00% | – |
Q4 2019 | $15,000 | +7.1% | 5,723 | +47.8% | 0.00% | – |
Q3 2019 | $14,000 | +7.7% | 3,871 | +3.5% | 0.00% | – |
Q2 2019 | $13,000 | +550.0% | 3,739 | +502.1% | 0.00% | – |
Q4 2018 | $2,000 | +100.0% | 621 | +104.3% | 0.00% | – |
Q3 2018 | $1,000 | -50.0% | 304 | -2.9% | 0.00% | – |
Q2 2018 | $2,000 | -98.1% | 313 | -97.5% | 0.00% | – |
Q4 2017 | $104,000 | -22.4% | 12,738 | 0.0% | 0.00% | – |
Q3 2017 | $134,000 | -32.3% | 12,738 | -28.8% | 0.00% | – |
Q2 2017 | $198,000 | +32.0% | 17,890 | 0.0% | 0.00% | – |
Q1 2017 | $150,000 | +23.0% | 17,890 | 0.0% | 0.00% | – |
Q4 2016 | $122,000 | +2340.0% | 17,890 | +633.2% | 0.00% | – |
Q2 2013 | $5,000 | – | 2,440 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |